Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Merrill, Joan
One or more keywords matched the following items that are connected to Merrill, Joan
Item TypeName
Concept Antibodies, Anti-Idiotypic
Concept Antibodies, Bacterial
Concept Antibodies, Monoclonal
Concept Antibodies, Antinuclear
Concept Antibodies, Antiphospholipid
Concept Antibodies, Anticardiolipin
Concept Antibodies, Monoclonal, Murine-Derived
Concept Antibodies, Monoclonal, Humanized
Academic Article Antibodies to periodontogenic bacteria are associated with higher disease activity in lupus patients.
Academic Article Autoantibody-positive healthy individuals with lower lupus risk display a unique immune endotype.
Academic Article Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding protein.
Academic Article Identification and characterization of a peptide mimetic that may detect a species of disease-associated anticardiolipin antibodies in patients with the antiphospholipid syndrome.
Academic Article Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study.
Academic Article Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus.
Academic Article Rituximab: wanted dead or alive...
Academic Article Ending the 50-year drought of FDA drug approval for SLE.
Academic Article Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort.
Academic Article Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.
Academic Article Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.
Academic Article Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension Study.
Academic Article Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production.
Academic Article Why, why, why de-lupus (does so badly in clinical trials).
Academic Article Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial.
Academic Article Clinical and Serologic Features in Patients With Incomplete Lupus Classification Versus Systemic Lupus Erythematosus Patients and Controls.
Academic Article Anifrolumab, an Anti-Interferon-a Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.
Academic Article Contribution of Socioeconomic Status to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes Among Women With Systemic Lupus Erythematosus.
Academic Article Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.
Academic Article Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus.
Academic Article A role for the polymorphism at position 247 of the beta2-glycoprotein I gene in the generation of anti-beta2-glycoprotein I antibodies in the antiphospholipid syndrome.
Academic Article Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
Academic Article The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis.
Academic Article Do antiphospholipid antibodies develop for a purpose?
Academic Article New directions in the treatment of systemic lupus erythematosus.
Academic Article Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
Academic Article Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus.
Academic Article Subcutaneous tocilizumab versus placebo in combination with disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
Academic Article A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-a) in patients with systemic lupus erythematosus (ROSE).
Academic Article Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
Academic Article Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus.
Academic Article Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab.
Academic Article Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index.
Academic Article Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis.
Academic Article Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
Academic Article Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE.
Academic Article Appropriate management of antiphospholipid-related pregnancy in women without lupus who have low titer autoantibodies.
Academic Article What causes the antiphospholipid syndrome?
Academic Article Which antiphospholipid antibody tests are most useful?
Academic Article Two pathways of CD11b/CD18-mediated neutrophil aggregation with different involvement of protein kinase C-dependent phosphorylation.
Academic Article IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
Academic Article A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
Academic Article Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials.
Academic Article Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
Academic Article Differential expression of the transcription factor ARID3a in lupus patient hematopoietic progenitor cells.
Academic Article Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes.
Academic Article Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial.
Academic Article Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.
Academic Article Low frequency of flares during pregnancy and post-partum in stable lupus patients.
Academic Article SR proteins are autoantigens in patients with systemic lupus erythematosus. Importance of phosphoepitopes.
Academic Article Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial.
Academic Article Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significance.
Academic Article Diagnosis of the antiphospholipid syndrome: how far to go?
Academic Article Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosus.
Academic Article Antiphospholipid syndrome: what's new in understanding antiphospholipid antibody-related stroke?
Academic Article Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
Academic Article What was wrong and might now go right with clinical trials for lupus?
Academic Article A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.
Academic Article Novel evidence-based systemic lupus erythematosus responder index.
Academic Article Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity.
Academic Article Safety profile and clinical activity of sifalimumab, a fully human anti-interferon a monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study.
Academic Article Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus.
Academic Article Monitoring cartilage loss in the hands and wrists in rheumatoid arthritis with magnetic resonance imaging in a multi-center clinical trial: IMPRESS (NCT00425932).
Academic Article Efficacy and safety of belimumab in patients with rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled, dose-ranging Study.
Academic Article PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes.
Academic Article Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA.
Academic Article Sifalimumab, an anti-interferon-a monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.
Academic Article Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.
Academic Article Kidney Outcomes and Risk Factors for Nephritis (Flare/De Novo) in a Multiethnic Cohort of Pregnant Patients with Lupus.
Academic Article Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis.
Academic Article New Trials in Lupus and where Are we Going.
Academic Article High prevalence of antiphospholipid antibodies in patients taking procainamide.
Grant Polymorphisms of Antiphospholipid Protein Antigens
Grant SPORADIC MECHANISM OF THE ANTIPHOSPHOLIPID SYNDROME
Grant SPORADIC MECHANISM OF THE ANTIPHOSPHOLIPID SYNDROME
Academic Article Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset.
Academic Article Anifrolumab reduces flare rates in patients with moderate to severe systemic lupus erythematosus.
Academic Article Immune Response to Enterococcus gallinarum in Lupus Patients Is Associated With a Subset of Lupus-Associated Autoantibodies.
Academic Article Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
Academic Article Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials.
Academic Article Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials.
Academic Article Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus.
Search Criteria
  • Antibodies